Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 106-115 , March 2008

Differential effect of low-dose thiazides on the renin angiotensin system in genetically hypertensive and normotensive rats

Received 6 June 2007 ,Accepted 6 October 2007.

References 

  1. Freis ED. How diuretics lower blood pressure. Am Heart J. 1983;106:185–187
  2. Birkenhager WH. Diuretics and blood pressure reduction: physiologic aspects. J Hypertens Suppl. 1990;8:S3–S7
  3. Calder JA, Schachter M, Sever PS. Direct vascular actions of hydrochlorothiazide and indapamide in isolated small vessels. Eur J Pharmacol. 1992;220:19–26
  4. Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension. 1999;33:1043–1048
  5. Colas B, Slama M, Masson H, Colas JL, Collin T, Arnould ML, et al. Direct vascular actions of methyclothiazide and indapamide in aorta of spontaneously hypertensive rats. Fundam Clin Pharmacol. 2000;14:363–368
  6. Zhu Z, Zhu S, Liu D, Cao T, Wang L, Tepel M. Thiazide–like diuretics attenuate agonist–induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension. 2005;45:233–239
  7. Chan PS, Ronsberg MA, Cervoni P. Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats. Clin Exp Hypertens A. 1982;4:1019–1034
  8. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:4–9
  9. Freis ED. Studies in hemodynamics and hypertension. Hypertension. 2001;38:1–5
  10. Hughes AD. How do thiazide and thiazide–like diuretics lower blood pressure?. J Renin Angiotensin Aldosterone Syst. 2004;5:155–160
  11. Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, et al. Effects of renin–angiotensin system blockade on renal angiotensin–(1–7) forming enzymes and receptors. Kidney Int. 2005;68:2189–2196
  12. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, Brosnihan KB. Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2 (Lewis rat). Hypertension. 2003;42:781–786
  13. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, et al. Temporal–spatial expression of angiotensin–(1–7) and angiotensin converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2007;293:R169–R177
  14. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, et al. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2–dependent processing of angiotensin II. Am J Physiol Renal Physiol. 2007;292:F82–F91
  15. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1–7) in the spontaneously hypertensive rat. Peptides. 1993;14:883–891
  16. Lee D, DeQuattro V, Brosnihan KB, Ferrario CM. Benazepril therapy in hypertension: LVH regression related to neural tone, blood pressure non-responders have reflex increase in angiotensin (1–7) peptide. [Abstract] J Hypertens. 1992;10:S64
  17. Ackermann A, Fernandez–Alfonso MS, Sanchez de RR, Ortega T, Paul M, Gonzalez C. Modulation of angiotensin–converting enzyme by nitric oxide. Br J Pharmacol. 1998;124:291–298
  18. Ferrario CM, Trask AJ, Jessup JA. Advances in the biochemical and functional roles of angiotensin converting enzyme 2 and angiotensin–(1–7) in the regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289:H2281–H2290
  19. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin–converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383:45–51
  20. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG–(1–7) in the regulation of angiotensin–converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2006;290:C420–C426
  21. Nakamura S, Averill DB, Chappell MC, Diz DI, Brosnihan KB, Ferrario CM. Angiotensin receptors contribute to blood pressure homeostasis in salt–depleted SHR. Am J Physiol Regul Integr Comp Physiol. 2003;284:R164–R173
  22. Iyer SN, Averill DB, Chappell MC, Yamada K, Allred AJ, Ferrario CM. Contribution of angiotensin–(1–7) to blood pressure regulation in salt–depleted hypertensive rats. Hypertension. 2000;36:417–422
  23. Sampaio WO, Souza dos Santos RA, Faria–Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin–(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt–dependent pathways. Hypertension. 2007;49:185–192
  24. Su Z, Zimpelmann J, Burns KD. Angiotensin–(1–7) inhibits angiotensin II–stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 2006;69:2212–2218

 Support was provided by NIH (HL-51952, HL-56973), Unifi Inc., Greensboro, NC, and Farley-Hudson Foundation, Jacksonville, NC.

 Conflict of interest: none.

PII: S1933-1711(07)00204-5

doi: 10.1016/j.jash.2007.10.005

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 106-115 , March 2008

Article Tools

* Image Usage & Resolution